- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT06273982
Gedragsmatige telezorg in instellingen voor eerstelijnszorg met weinig middelen voor angst en depressie bij jongeren (STEP-UP)
Gedragsmatige telezorg in instellingen voor eerstelijnszorg met weinig middelen voor angst en depressie bij jongeren: een gerandomiseerde studie naar effectiviteitsimplementatie
The goal of this clinical trial is to test a brief, behavioral telehealth treatment program (STEP-UP) for depression and anxiety in youths (age 8-16 years old). Youths and families will be recruited through participating community health centers and will be randomly assigned to either: (a) receive STEP-UP care from providers at their health center or (b) be referred to care from local community mental health clinicians. Youth and families will be interviewed before treatment starts, 16 weeks later, and 32 weeks later to assess how youth are feeling. The main question the study aims to answer is whether STEP-UP improves youths functioning in daily life, anxiety symptoms, and depression symptoms. Researchers will compare STEP-UP to referral to community treatment-as-usual mental health services to see if STEP-UP is more effective.
Studie Overzicht
Toestand
Conditie
Studietype
Inschrijving (Geschat)
Fase
- Niet toepasbaar
Contacten en locaties
Studie Locaties
-
-
Oregon
-
Portland, Oregon, Verenigde Staten, 97227
- Kaiser Permanente Center for Health Research
-
-
Deelname Criteria
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
Accepteert gezonde vrijwilligers
Geslachten die in aanmerking komen voor studie
Beschrijving
Inclusion Criteria:
-
Youth is a patient in a participating community health center.
-
Youths meet criteria for clinically significant anxiety and / or depression as indexed at baseline assessment by either:
- research diagnosis of anxiety (Social Anxiety Disorder, Generalized Anxiety Disorder, Separation Anxiety Disorder) and / or depressive disorder (Major Depressive Disorder, Persistent Depressive Disorder).
- scores in the clinically elevated range on a standardized anxiety and / or depression symptom measure .
-
Youth lives with a legal guardian (hereafter referred to as "parent") >= 50% of the time who consents to study participation.
-
Youth speaks English.
-
Parent speaks English or Spanish.
Exclusion Criteria:
-
Youth requires alternate treatment as indexed by:
- current clinically significant Post-Traumatic Stress Disorder symptoms (meets diagnostic criteria in research interview and / or scores in the clinically elevated range on a standardized symptom measure) at baseline.
- current suicidal ideation with plan at baseline and / or suicidal behavior within the last year.
- current substance dependence at baseline.
- experience of physical or sexual abuse within the six months prior to baseline.
- parent /guardian does not identify anxiety and / or depression as a treatment priority at baseline.
-
Youth is in an active, alternate psychosocial intervention for anxiety or depression that would be concurrent with study participation.
-
Youth is on an unstable regimen of psychotropic medication (i.e., receives medication but has not been at a stable dose for at least 8 weeks, or if medication has been discontinued for less than 4 weeks) at baseline.
-
Youth is receiving lithium or and anti-psychotic medication at baseline.
-
Youth is placed in a special education program for greater than 50% of the school day and / or youth school placement is below the second-grade level at baseline.
-
Youth is placed in foster care at baseline.
Studie plan
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: STAP-UP
|
STEP-UP consists of 8 to 12 sessions of behavioral therapy for anxiety and / or depression. Skills taught include relaxation, problem solving, and exposure / behavioral activation.
Andere namen:
|
|
Actieve vergelijker: BOOG
|
ARC consists of referral to community mental health treatment-as-usual. Families are provided psychoeducation about anxiety and depression and the benefits of treatment, lists of local community providers, and a problem-solving discussion about obstacles to obtaining care. |
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Children's Global Assessment Scale (CGAS)
Tijdsspanne: Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32)
|
Interviewer-rated youth functioning. Scores range from 1 to 100, and higher score indcate superior functioning. |
Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32)
|
|
Pediatric Anxiety Rating Scale (PARS)
Tijdsspanne: Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32). The PARS total severity score ranges from 0 to 30, with higher scores indicating greater anxiety severity.
|
Interviewer-rated symptoms of anxiety disorders, combining parent and youth report |
Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32). The PARS total severity score ranges from 0 to 30, with higher scores indicating greater anxiety severity.
|
|
Children's Depression Rating Scale -- Revised (CDRS-R)
Tijdsspanne: Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32). The CDRS-R total severity score ranges from 17 to 113, with higher scores indicating greater depression symptom severity.
|
Interviewer rated symptoms of depressive disorders, combining parent and youth report |
Measured at baseline (Week 0) and follow-up assessments (Week 16 and Week 32). The CDRS-R total severity score ranges from 17 to 113, with higher scores indicating greater depression symptom severity.
|
Medewerkers en onderzoekers
Sponsor
Onderzoekers
- Hoofdonderzoeker: V. Robin Weersing, PhD, San Diego State University
- Hoofdonderzoeker: Frances Lynch, PhD, Kaiser Permanente
Publicaties en nuttige links
Studie record data
Bestudeer belangrijke data
Studie start (Werkelijk)
Primaire voltooiing (Geschat)
Studie voltooiing (Geschat)
Studieregistratiedata
Eerst ingediend
Eerst ingediend dat voldeed aan de QC-criteria
Eerst geplaatst (Werkelijk)
Updates van studierecords
Laatste update geplaatst (Werkelijk)
Laatste update ingediend die voldeed aan QC-criteria
Laatst geverifieerd
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- HS-2023-0281-SMT
- 1R01MH131698 (Subsidie/contract van de Amerikaanse NIH)
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .